Skip to main content
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

600

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

600 results for “Ophthalmitis”

Learn how ShareScore rates datasets ↗
zenodo32/100

FIGURES 69–80. Sternite 8 in A review of Ophthalmitis Fletcher, 1979 in China, with descriptions of four new species (Lepidoptera: Geometridae, Ennominae)

FIGURES 69–80. Sternite 8 of male abdomen of Ophthalmitis. 69, O. albosignaria albosignaria; 70, O. pertusaria; 71, O. sinensium; 72, O. dissita sp. nov.; 73, O. irrorataria; 74, O. herbidaria; 75, O. siniherbida; 76, O. cordularia; 77, O. longiprocessa sp. nov.; 78, O. brevispina sp. nov.; 79, O. tumefacta sp. nov.; 80, O. xanthypochlora. Scale bar = 1 mm.

opennotspecifiedDec 2011View details →
zenodo32/100

FIGURES 57–68 in A review of Ophthalmitis Fletcher, 1979 in China, with descriptions of four new species (Lepidoptera: Geometridae, Ennominae)

FIGURES 57–68. Aedeagus of Ophthalmitis. 57, O. albosignaria albosignaria; 58, O. pertusaria; 59, O. sinensium; 60, O. dissita sp. nov.; 61, O. irrorataria; 62, O. herbidaria; 63, O. siniherbida; 64, O. cordularia; 65, O. longiprocessa sp. nov.; 66, O. brevispina sp. nov.; 67, O. tumefacta sp. nov.; 68, O. xanthypochlora. Scale bar = 1 mm.

opennotspecifiedDec 2011View details →
zenodo32/100

FIGURES 51–56 in A review of Ophthalmitis Fletcher, 1979 in China, with descriptions of four new species (Lepidoptera: Geometridae, Ennominae)

FIGURES 51–56. Male genitalia of Ophthalmitis. 51, O. siniherbida; 52, O. cordularia; 53, O. longiprocessa sp. nov.; 54, O. brevispina sp. nov.; 55, O. tumefacta sp. nov.; 56, O. xanthypochlora. Scale bar = 1 mm.

opennotspecifiedDec 2011View details →
zenodo32/100

FIGURES 45–50 in A review of Ophthalmitis Fletcher, 1979 in China, with descriptions of four new species (Lepidoptera: Geometridae, Ennominae)

FIGURES 45–50. Male genitalia of Ophthalmitis. 45, O. albosignaria albosignaria; 46, O. pertusaria; 47, O. sinensium; 48, O. dissita sp. nov.; 49, O. irrorataria; 50, O. herbidaria. Scale bar = 1 mm.

opennotspecifiedDec 2011View details →
zenodo32/100

FIGURES 1–12 in A review of Ophthalmitis Fletcher, 1979 in China, with descriptions of four new species (Lepidoptera: Geometridae, Ennominae)

FIGURES 1–12. Adults of Ophthalmitis, habitus. 1–4. O. albosignaria albosignaria. 1, male, upperside; 2, male, underside; 3, female, upperside; 4, female, underside; 5–8. O. pertusaria. 5, male, upperside; 6, male, underside; 7, female, upperside; 8, female, underside; 9–12. O. sinensium. 9, male, upperside; 10, male, underside; 11, female, upperside; 12, female, underside. Scale bar = 1 cm.

opennotspecifiedDec 2011View details →
zenodo32/100

FIGURES 31–44 in A review of Ophthalmitis Fletcher, 1979 in China, with descriptions of four new species (Lepidoptera: Geometridae, Ennominae)

FIGURES 31–44. Adults of Ophthalmitis, habitus. 31–34. O. longiprocessa sp. nov. 31, male, holotype, upperside; 32, male, holotype, underside; 33, female, paratype, upperside; 34, female, paratype, underside; 35–38. O. brevispina sp. nov. 35, male, holotype, upperside; 36, male, holotype, underside; 37, female, paratype, upperside; 38, female, paratype, underside. 39–42. O. tumefacta sp. nov. 39, male, holotype, upperside; 40, male, holotype, underside; 41, female, paratype, upperside; 42, female, paratype, underside. 43–44. O. xanthypochlora. 43, male, upperside; 44, male, underside. Scale bar = 1 cm.

opennotspecifiedDec 2011View details →
zenodo32/100

FIGURES 13–30 in A review of Ophthalmitis Fletcher, 1979 in China, with descriptions of four new species (Lepidoptera: Geometridae, Ennominae)

FIGURES 13–30. Adults of Ophthalmitis, habitus. 13–14. O. dissita sp. nov., holotype. 13, male, upperside; 14, male, underside. 15–18. O. irrorataria. 15, male, upperside; 16, male, underside; 17, female, upperside; 18, female, underside; 19–22. O. herbidaria. 19, male, upperside; 20, male, underside; 21, female, upperside; 22, female, underside; 23–26. O. siniherbida. 23, male, upperside; 24, male, underside; 25, female, upperside; 26, female, underside; 27–30. O. cordularia. 27, male, upperside; 28, male underside; 29, female, upperside; 30, female, underside. Scale bar = 1 cm.

opennotspecifiedDec 2011View details →
zenodo32/100

Raw data for Hybrid micellar liquid chromatography separation of brimonidine tartrate and brinzolamide. Retention study and quantification in fixed dose ophthalmic suspensions

<p>Raw data for optimization of the chromatographic conditions and calibration curve construction</p>

opencc-by-4.0Nov 2024View details →
zenodo32/100

2023 IEEE SPS Video and Image Processing (VIP) Cup: Ophthalmic Biomarker Detection

<p>Ophthalmic clinical trials that study treatment efficacy of eye diseases are performed with a specific purpose and a set of procedures that are predetermined before trial initiation. Hence, they result in a controlled data collection process with gradual changes in the state of a diseased eye. In general, these data include 1D clinical measurements and 3D optical coherence tomography (OCT) imagery. Physicians interpret structural biomarkers for every patient using the 3D OCT images and clinical measurements to make personalized decisions for every patient.</p> <p>Two main challenges in medical image processing has been <em>generalization</em> and <em>personalization</em>.</p> <p>Generalization aims to develop algorithms that work well across diverse patients and scenarios, providing standardized and widely applicable solutions. Personalization, in contrast, tailors algorithms to individual patients based on their unique characteristics, optimizing diagnosis and treatment planning. Generalization offers broad applicability but may overlook individual variations. Personalization provides tailored solutions but requires patient-specific data. While deep learning has shown an affinity towards generalization, it is lacking in personalization.</p> <p>The presence and absence of biomarkers is a personalization challenge rather than a generalization challenge. The variation within OCT scans of patients between visits can be minimal while the difference in manifestation of the same disease across patients may be substantial. The domain difference between OCT scans can arise due to pathology manifestation across patients, clinical labels, and the visit along the treatment process when the scan is taken. Morphological, texture, statistical and fuzzy image processing techniques through adaptive thresholds and preprocessing may prove substantial to overcome these fine-grained challenges. This challenge provides the data and application to address personalization.</p>

opencc-by-4.0Jun 2023View details →
zenodo32/100

2023 IEEE SPS Video and Image Processing (VIP) Cup: Ophthalmic Biomarker Detection Phase 2

<p>Ophthalmic clinical trials that study treatment efficacy of eye diseases are performed with a specific purpose and a set of procedures that are predetermined before trial initiation. Hence, they result in a controlled data collection process with gradual changes in the state of a diseased eye. In general, these data include 1D clinical measurements and 3D optical coherence tomography (OCT) imagery. Physicians interpret structural biomarkers for every patient using the 3D OCT images and clinical measurements to make personalized decisions for every patient.</p> <p>Two main challenges in medical image processing has been&nbsp;<em>generalization</em>&nbsp;and&nbsp;<em>personalization</em>.</p> <p>Generalization aims to develop algorithms that work well across diverse patients and scenarios, providing standardized and widely applicable solutions. Personalization, in contrast, tailors algorithms to individual patients based on their unique characteristics, optimizing diagnosis and treatment planning. Generalization offers broad applicability but may overlook individual variations. Personalization provides tailored solutions but requires patient-specific data. While deep learning has shown an affinity towards generalization, it is lacking in personalization.</p> <p>The presence and absence of biomarkers is a personalization challenge rather than a generalization challenge. The variation within OCT scans of patients between visits can be minimal while the difference in manifestation of the same disease across patients may be substantial. The domain difference between OCT scans can arise due to pathology manifestation across patients, clinical labels, and the visit along the treatment process when the scan is taken. Morphological, texture, statistical and fuzzy image processing techniques through adaptive thresholds and preprocessing may prove substantial to overcome these fine-grained challenges. This challenge provides the data and application to address personalization.</p> <p>&nbsp;</p> <p>These files constitute the second phase of the VIP CUP 2023 Challenge at ICIP 2023. This test set has a more general patient base than the first one and as such is a better indicator of the performance of models. This test set was created by taking a subset of the data from a publicly available OCT dataset and then asking our medical partners to provide fine-grained biomarker labels for the competition. We provide the citation for the source of these images below:&nbsp;</p> <p>Kermany D, Goldbaum M, Cai W et al. Identifying Medical Diagnoses and Treatable Diseases by Image-Based Deep Learning. Cell. 2018; 172(5):1122-1131. doi:10.1016/j.cell.2018.02.010.</p> <p>&nbsp;</p> <p>This zenodo repository contains the images and submission template file needed for the second phase of the competition.</p>

opencc-by-4.0Aug 2023View details →
ClinicalTrials.gov32/100

Safety and Efficacy of ST-100 (Vezocolmitide) Ophthalmic Solution 60 μg/ml Ophthalmic Solution in Subjects Diagnosed With Dry Eye Disease (DED)

ClinicalTrials.gov study NCT06178679. IPD Sharing: Not stated. Countries: 1. Publications: 8.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Investigation of Preservative-Free Ophthalmic Solution in Ocular Dryness

ClinicalTrials.gov study NCT05778942. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Use of 3% Diquafosol Topical Ophthalmic Solution for Diabetic Dry Eye

ClinicalTrials.gov study NCT05193331. IPD Sharing: NO. Countries: 1. Publications: 27.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Non-inferiority of PRO-122 Ophthalmic Solution vs KRYTANTEK Ofteno® in Glaucoma or Ocular Hypertension (CONFORTK)

ClinicalTrials.gov study NCT03257813. IPD Sharing: NO. Countries: 0. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Lifitegrast 5% Ophthalmic Solution and Contact Lens Dryness

ClinicalTrials.gov study NCT03686878. IPD Sharing: Not stated. Countries: 1. Publications: 3.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

A Phase 3 Efficacy Study of Pilocarpine HCl Ophthalmic Solution (AGN-190584) in Participants With Presbyopia

ClinicalTrials.gov study NCT03857542. IPD Sharing: YES. Countries: 1. Publications: 0.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov32/100

Allogeneic Tissue Engineering (Nanostructured Artificial Human Cornea) in Patients With Corneal Trophic Ulcers in Advanced Stages, Refractory to Conventional (Ophthalmic) Treatment

ClinicalTrials.gov study NCT01765244. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

A Study of Intra-Ophthalmic Artery Topotecan Infusion for the Treatment of Retinoblastoma

ClinicalTrials.gov study NCT01466855. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Safety and Tolerability of Preservative-free Polyhexamethylene Biguanide (PHMB) Ophthalmic Solution in Healthy Subjects

ClinicalTrials.gov study NCT02506257. IPD Sharing: UNDECIDED. Countries: 0. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Topical Brinzolamide Ophthalmic Suspension Versus Placebo in the Treatment of Infantile Nystagmus Syndrome

ClinicalTrials.gov study NCT01312402. IPD Sharing: Not stated. Countries: 1. Publications: 7.

restrictedIPD-UNDECIDEDFeb 2026View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record